According to a new market research study of “Asia Pacific Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Analysis by Vaccine Type and Route Of Administration, Asia Pacific typhoid fever vaccines market is projected to reach US$ 135.79 million in 2027 from US$ 64.75 million in 2019. The market is estimated to grow at CAGR of 10.0% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific typhoid fever vaccines market and the factors driving market along with those that act as hindrances.
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Asia Pacific typhoid fever vaccines market is expected to grow owing to key factors such as increasing prevalence of typhoid fever in Asia and typhoid immunizations programs. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Asia Pacific typhoid fever vaccines market are GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., PT Bio Farma, BIO-MED, BHARAT BIOTECH among others.
The report segments Asia Pacific Typhoid Fever Vaccines market as follows:
By Vaccine Type
By Route of Administration
By Country
Reasons to Buy
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Asia Pacific typhoid fever vaccines market is expected to grow owing to key factors such as increasing prevalence of typhoid fever in Asia and typhoid immunizations programs. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Asia Pacific typhoid fever vaccines market are GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., PT Bio Farma, BIO-MED, BHARAT BIOTECH among others.
The report segments Asia Pacific Typhoid Fever Vaccines market as follows:
By Vaccine Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
By Country
- India
- China
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific typhoid fever vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Typhoid Fever Vaccines Market Landscape
5. Asia Pacific Typhoid Fever Vaccines Market Key Market Dynamics
6. Typhoid Fever Vaccines Market - Asia Pacific Analysis
7. Typhoid Fever Vaccines Market - by Vaccine Type
8. Typhoid Fever Vaccines Market Analysis - by Route of Administration
9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GlaxoSmithKline plc
- Shanghai institute of biological products co., Ltd
- PT Bio Farma
- BIO-MED
- BHARAT BIOTECH